143 related articles for article (PubMed ID: 23550721)
1. Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma.
Rieneck K; Bak M; Jønson L; Clausen FB; Krog GR; Tommerup N; Nielsen LK; Hedegaard M; Dziegiel MH
Transfusion; 2013 Nov; 53(11 Suppl 2):2892-8. PubMed ID: 23550721
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing for Antenatal Prediction of KEL1 Blood Group Status.
Rieneck K; Clausen FB; Dziegiel MH
Methods Mol Biol; 2015; 1310():115-21. PubMed ID: 26024630
[TBL] [Abstract][Full Text] [Related]
3. Prenatal determination of genotypes Kell and Cellano in at-risk pregnancies.
Spence WC; Maddalena A; Demers DB; Bick DP
J Reprod Med; 1997 Jun; 42(6):353-7. PubMed ID: 9219123
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.
Li Y; Finning K; Daniels G; Hahn S; Zhong X; Holzgreve W
Prenat Diagn; 2008 Mar; 28(3):203-8. PubMed ID: 18241084
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2.
Lee S; Bennett PR; Overton T; Warwick R; Wu X; Redman CM
Am J Obstet Gynecol; 1996 Aug; 175(2):455-9. PubMed ID: 8765268
[TBL] [Abstract][Full Text] [Related]
6. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
[TBL] [Abstract][Full Text] [Related]
7. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
8. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma.
Finning K; Martin P; Summers J; Daniels G
Transfusion; 2007 Nov; 47(11):2126-33. PubMed ID: 17958542
[TBL] [Abstract][Full Text] [Related]
9. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
[TBL] [Abstract][Full Text] [Related]
10. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
11. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers.
Hessner MJ; McFarland JG; Endean DJ
Transfusion; 1996 Jun; 36(6):495-9. PubMed ID: 8669079
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
Scheffer PG; van der Schoot CE; Page-Christiaens GC; de Haas M
BJOG; 2011 Oct; 118(11):1340-8. PubMed ID: 21668766
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Antenatal Determination of Fetal Blood Group Using Next-Generation Sequencing.
Rieneck K; Clausen FB; Dziegiel MH
Cold Spring Harb Perspect Med; 2015 Oct; 6(1):a023093. PubMed ID: 26511760
[TBL] [Abstract][Full Text] [Related]
14. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.
Doescher A; Petershofen EK; Wagner FF; Schunter M; Müller TH
Transfusion; 2013 Feb; 53(2):353-62. PubMed ID: 22691192
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
17. [Anti-K antibodies in pregnant women and genotyping of K antigen in foetuses].
Zupańska B; Nowaczek-Migas M; Michalewska B; Wielgoś M; Orzińska A
Ginekol Pol; 2008 Jun; 79(6):410-4. PubMed ID: 18652128
[TBL] [Abstract][Full Text] [Related]
18. Maldi-TOF mass spectrometry for analyzing cell-free fetal DNA in maternal plasma.
Ding C
Methods Mol Biol; 2008; 444():253-67. PubMed ID: 18425487
[TBL] [Abstract][Full Text] [Related]
19. Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease.
Chu T; Bunce K; Hogge WA; Peters DG
Bioinformatics; 2009 May; 25(10):1244-50. PubMed ID: 19307238
[TBL] [Abstract][Full Text] [Related]
20. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications.
Avent ND; Madgett TE; Maddocks DG; Soothill PW
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):175-9. PubMed ID: 19262379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
